Skip to main content

Articles

Introduction
Progress in Cancer Care: Challenges and Opportunities
Read More
Perspectives
Increasing Importance of Oncology Drug Management for Payers
Read More
Perspectives
The Changing Face of Cancer Care: Evolution to a Collaborative Model
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Read More
FDA Approvals
Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer
Read More
Perspectives
Reflections on Japan’s Complex Medical Culture
Read More
Practice Management
Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina
Stakeholder Perspective
Stroking This South Carolina Model: Will It Play in Peoria?
Read More
Practice Management
The Race to Open Enrollment: Critical Success Factors for Exchanges
Read More
Practice Management
US Propofol Drug Shortages: A Review of the Problem and Stakeholder Analysis
Stakeholder Perspective
Drug Shortages in the United States Continue to Undermine Patient Care
Read More
Conference Highlights AMCP
Step-Up Therapy Program for Anti-Inflammatory Biologic Agents Does Not Increase Cost Nor Adversely Affect Patient Outcomes
Read More
Page 177 of 244
Results 1761 - 1770 of 2436